Potomac Capital Management Inc. 13D/13G Filings for Harvard Bioscience, Inc. (HBIO)

Potomac Capital Management Inc. 13D and 13G filings for Harvard Bioscience, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
3:14 pm
Sale
2020-12-3113GHarvard Bioscience, Inc.
HBIO
Potomac Capital Management Inc.4,500
0.010%
-2,082,901decrease
(-99.78%)
Filing